# Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients

> **NCT03829852** · — · COMPLETED · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 716 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Regorafenib

## Key facts

- **NCT ID:** NCT03829852
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-11
- **Primary completion:** 2020-12-08
- **Final completion:** 2020-12-08
- **Target enrollment:** 716 (ACTUAL)
- **Last updated:** 2021-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03829852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03829852, "Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03829852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*